Quote:Donald Trump Isn’t a Manchurian Candidate
Trump and Putin are using each other.
By Franklin Foer
Quote:Pause to consider: The Republican presidential nominee wants another country to steal secrets from the United States and not in the interests of exposing military misadventures or for some high-minded reason. He wants to expose American secrets in order to hurt his foe. Nixonian doesn’t even begin to capture it.
But perhaps, 'f*cked up in the head' does? LOL!
![]()
Photo illustration by Natalie Matthews-Ramo. Photos by Aleksey Nikolskyi and Sara D. Davis at Getty Images
Donald Trump and Vladimir Putin are both lying. Only one of them, however, is cunning; the other is gaffing his way toward treason. Trump has emphatically denied ties to Russia—a claim refuted by his Twitter feed and a cursory Google search.
Putin says his government had nothing to do with the hack of the DNC computers, even though it carelessly left a trail of crumbs tracing back to his intelligence services. The cunning liar is exploiting the blundering one.
Let’s be clear: Trump isn’t a Manchurian candidate. He’s not taking orders from the Kremlin. As I wrote on Friday, Trump is a useful device for Putin—a way to hurt the United States and perhaps a way to exact revenge on Hillary Clinton.
Putin has made a habit of supporting far-right candidates who undermine his foes in Europe; perhaps he never could have imagined such a character taking root on American soil.
Trump’s reasons for aligning with Putin have been more innocent, if no less dangerous. Trump is a real estate guy who sucks up to power to get buildings built. And he desperately wanted to build in Russia—the dream of Trump Tower Moscow has been a constantly recurring one. “We will be in Moscow at some point,” he once proclaimed.
When he took his many trips to Moscow, Trump praised authorities so that he could get the necessary approvals. His kind words to Russian leaders and his personal style endeared him to the country’s new elite. Trump is baldly denying these efforts—“I have nothing to do with Russia,” he said on Wednesday.
It’s true that his Moscow building never broke ground, but Russian investment flowed to his properties. “Russians make up a pretty disproportionate cross-section of a lot of our assets,” Trump’s son, Donald Jr., once bragged. “We see a lot of money pouring in from Russia.” Or as Trump himself once put: “The Russian market is attracted to me.”
This investment wasn’t incidental to Trump: It was essential. After his 2004 bankruptcy, the big banks wouldn’t touch him. Who would?
He had a record of litigiousness and going belly up. But Russian investors helped prop up Trump’s megabuilding projects, which were crucial to his image as a man who makes things, not just a reality television star.
There would be no Trump SoHo, for instance, without capital from Russia. As one lawsuit alleges, the money arrived at Trump projects through an Icelandic investment fund “in favor” with Putin’s elite and through mysterious infusions of cash from Russia and Kazakhstan into the accounts of his partners.
It’s not hard to see why this dependence, and his fawning words about Putin, would endear him to the Kremlin. Putin would be foolish not to lend Trump a quiet hand. And, indeed, his inner circle has made little secret of its rooting interest in the Trump campaign. Russia Today, Putin’s primary propaganda vehicle, routinely trashes Hillary Clinton and praises Trump’s courageous stances.
Perhaps our intelligence community has a better sense of the ultimate goal of Russia’s hack. But it doesn’t take much imagination to describe the relationship between the Kremlin and Trump campaign as symbiotic.
Let’s review the events of the past few weeks. First, Trump softened the Republican Party’s stance on Ukraine; then Trump announced that he wouldn’t come rushing to the aid of NATO allies invaded by Russia.
That was followed by the leak of the Democratic National Committee emails, on the eve of the convention—an event that Julian Assange implied was intended to injure Hillary Clinton. It’s hard to imagine that this chain of events was coordinated. Yet Trump and Putin profited from one another in measurable ways.
At Wednesday’s press conference, Trump made clear that he wasn’t standing in Putin’s way. He wouldn’t ask Putin to desist from hacking his enemy; instead, he mused aloud about how he hoped Russia would obtain Hillary Clinton’s email.
“Russia, if you’re listening, I hope you’re able to find the 30,000 emails that are missing,” he announced. The only way to procure those emails would be to steal them.
What’s more, those aren’t campaign documents from low-level staffers or hacks at a political party: He’s advocating the Russians steal documents produced by the secretary of state—and he wants to broadcast them to the world. (Later he suggested it would perhaps be more appropriate for Russia to share them with the FBI.)
It was grossly negligent for Hillary Clinton to leave her emails so exposed, and she should be shamed and hounded for her indifference to cybersecurity. But that’s a sin of omission. By any moral calculus, Trump just committed a far worse offense. He advocated that a foreign country commit espionage in order to weaken his political opponent.
Pause to consider: The Republican presidential nominee wants another country to steal secrets from the United States and not in the interests of exposing military misadventures or for some high-minded reason. He wants to expose American secrets in order to hurt his foe. Nixonian doesn’t even begin to capture it.
Donald Trump Isn’t a Manchurian Candidate Trump and
Top 10 Most Recent News Articles
Warehouse Strike Over Pensions Jolts AGNE Operations
AGNE Feels Heat as Teamsters Strike Over Pensions Damn near thought we'd seen it all, but here we are, bearings rattled by yet another strike at a time when disruption seems to be the tune of the day. Over 255 members of Teamsters Local 633 have locked horns with Associated Grocers Northeast (AGNE) in Pembroke, New Hampshire. It's not about nickel-and-diming over a pay...
Continue Reading
AI in Healthcare: Real Results Unveiled at HLTH 2026
Transforming Healthcare with AI The landscape of healthcare is constantly evolving, and this time, we're diving deep into how AI is shaking things up. MCG Health and Telligen, both heavyweights in the health sector, are stepping into the limelight at the HLTH 2026 conference. This ain't just any run-of-the-mill presentation; it's where the rubber meets the road in...
Continue Reading
Marini SkinSolutions Wins with Night Zyme Complex
Shaking Up the Skincare Scene You don't often see a skincare product snag three prestigious awards in one year, but that's exactly what's unfolding for Marini SkinSolutions. This time, their Night Zyme® Overnight Glass Skin Resurfacing Complex grabbed the 2026 Shop TODAY Ageless Beauty Award. It’s turning heads and not just in beauty aisles but among investors eyeing a...
Continue Reading
GAC Hits Record with 223,000 Units Exported in 2026
GAC Gaining Ground Globally in 2026 China's GAC is making waves with its recent export figures. They've blitzed past the competition, exporting 223,000 units from January to October 2026. That's not just a number, it’s a record, with October alone seeing a hefty 26,017 units shipped—marking an impressive 80.8% growth compared to last year. A Strategic Push in Europe...
Continue Reading
Mondego Bio Charges Ahead with Cancer Therapy Trials
Cracking Cancer's Code: Mondego's Bold Move Big news from Portugal today—a quiet town called Cantanhede is now the epicenter of a potential game-changer in cancer therapy. Mondego Bio, with its small-molecule innovator MB?388, is diving headfirst into a Phase 1 clinical study. If you're scratching your head about the significance, let me spell it out: this is an attempt...
Continue Reading
Bram Schot Steers Marelli Through Chapter 11 Resurgence
So, Marelli's rolling out the heavy artillery with the appointment of Bram Schot as their future Chair. This isn't just reshuffling a few chairs on the deck of a wobbly ship. No, Marelli's emergence from Chapter 11, with Schot at the helm, is more akin to a full-blown course correction. The man comes seasoned, having braved the corporate gales at Audi, Mercedes-Benz, and...
Continue Reading
Attilio's Longevity Push: Science with a Personal Touch
Reimagining Longevity: Beyond Just Adding Years Guess what? Living longer isn't just about reaching the milestone of blowing out 100 birthday candles. That's the message Attilio drilled home during their recent Longevity Event. And let me tell you, it was quite a doozy—from what went down at Stanford to a deep dive at the Buck Institute, it was an eye-opening affair....
Continue Reading
SKF's Industrial Push: Energy Efficiency at COP31
SKF's Green Initiative: A Major Step Forward You ever find yourself in a room full of big players, each trying to outdo the other? That's the stage set for SKF at COP31, where they're not just strutting around showing off but actually offering some substance—a rarity in these highbrow gatherings. They're juicing up the talk around energy efficiency and circularity...
Continue Reading
Dill Dinkers Eyes Next Growth Phase with Local Deal
A Leap Toward Future Growth You know, not every day does a company manage to turn its early beginnings into a robust franchise system, but Dill Dinkers seems to be onto something here. This pickleball outfit is tossing its original Maryland clubs to local hands, and it’s not just a transaction—it’s a calculated play intending to solidify their expansion path...
Continue Reading
FirstService Jolts Mira Mar Redesign Masterplan
Sarasota's Mira Mar Finds Its Match Holy smokes! Sarasota's making waves again as Mira Mar, the high-end luxury condominium development, ropes in FirstService Residential to give it that extra oomph. Now, we're talkin’ about a real shake-up in downtown Sarasota real estate. The game here isn’t just grabbing a slice of the pie; it's the whole damn pie. Luxury Living...
Continue ReadingTop 5 Most Recently Viewed Articles
Daily Market Insights: Strategies forKey Tech Stocks Today
Good Morning Traders! Key Insights for Top Stocks Today’s Market Clubhouse Morning Memo focuses on essential trading strategies for prominent stocks such as SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, and TSLA. These stocks have shown some intriguing movements in recent sessions, and traders need to remain vigilant for potential opportunities. Understanding Market Dynamics...
Continue Reading
Rexel's Recent Share Buyback Activity Overview
Rexel's Recent Share Buyback Activity Overview Rexel, a key player in the electrical distribution sector, has made notable strides in its share acquisition strategy. This initiative not only demonstrates Rexel's commitment to enhancing shareholder value, but it also reflects robust financial health and proactive management. Overview of Share Repurchase Authorization Under...
Continue Reading
Mount Logan Capital Reports Strong Q3 2025 Financial Performance
Exciting Financial Developments for Mount Logan Capital Inc. Mount Logan Capital Inc. (NASDAQ: MLCI) has recently announced a series of impressive financial results for the third quarter. As they continue to position themselves in the competitive landscape of asset management and insurance solutions, their performance metrics indicate a robust growth trajectory. Key...
Continue Reading
GrayMatter Robotics Competes for DoD Innovation Triumph
GrayMatter Robotics Competes for DoD Innovation Triumph Selected from a field of 59 elite innovators, GrayMatter's adaptive robotics are set to transform defense maintenance through high-speed, AI-driven automation. GrayMatter Robotics, recognized as a leader in AI-driven surface finishing technologies, has made headlines as one of five finalists in the Maintenance...
Continue Reading
Surrozen Secures $10 Million Milestone in Retinal Disease Research
Surrozen Achieves Significant Milestone Payment Surrozen, Inc. is making noteworthy advancements in biotechnology, particularly through its groundbreaking research aimed at treating retinal diseases. Recently, the company celebrated a significant milestone: a $10 million payment resulting from its partnership with Boehringer Ingelheim for the development of SZN-413....
Continue Reading